Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study

Abstract Background Tigecycline is a vital antibiotic treatment option for infections caused by multiresistant bacteria in the intensive care unit (ICU). Acute kidney injury (AKI) is a common complication in the ICU requiring continuous renal replacement therapy (CRRT), but pharmacokinetic data for...

Full description

Bibliographic Details
Main Authors: A. Broeker, S. G. Wicha, C. Dorn, A. Kratzer, M. Schleibinger, F. Kees, A. Heininger, M. G. Kees, H. Häberle
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Critical Care
Subjects:
Tigecycline
Population pharmacokinetics
NONMEM
Dosing
Renal replacement therapy
CVVHD
Online Access:http://link.springer.com/article/10.1186/s13054-018-2278-4

Internet

http://link.springer.com/article/10.1186/s13054-018-2278-4

Similar Items